Pregnant women with COVID- 19 and its consequences for newborns

• Autor(a) principal: Vieira, Ana Rafaela Labouré de Carvalho
• Data de Publicação: 2021
• Outros Autores: Rocha, Ana Júlia Carvalho, Faria, André Luiz Oliveira de, Oliveira, Raphael Romanelli Andrade de, Barros, Gérsika Bitencourt Santos
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/20506
• topic: Embarazo; COVID-19; Recién nacido; Recién nacido.; Gravidez; COVID-19; Recém-nascido; Recém-nascido.; Pregnancy; COVID -19; Newborn.; newborn

The COVID-19 pandemic, a respiratory disease caused by the coronavirus genus, raised questions regarding the risk classification of pregnant and postpartum women. Although the vast majority of the group remains asymptomatic or with classic symptoms of the disease (cough, fever, runny nose), the infection is related to an increase in adverse pregnancy events, such as pre-eclampsia and premature rupture of the placenta, in addition to increasing the chances of an intrauterine fetal death. This problem is reflected in newborns, which can be affected by maternal contamination, either because of the greater chances of prematurity or the risk of also being infected. Thus, the objective of this study is to evaluate in the literature the main consequences recorded by COVID-19 in newborns of mothers infected with the virus. For this, we searched for the descriptors in the platforms Google Scholar, LILACS, PubMED and SciELO, finding a total of 18736 articles. After applying the inclusion and exclusion criteria, 117 articles remained to be analyzed, of which 26 make up the current sample. Vertical transmission is still poorly reported, with the most common gestational manifestations forming pre-eclampsia, fetal distress and premature birth. In relation to newborns, most, when infected, do not present symptoms of the disease. Thus, it is concluded that further studies are needed to confirm the severity of COVID-19 in newborns of positive mothers, in order to improve the understanding of the needs and care of this group.